KADCYLA

Powder for concentrate for solution for infusion, 160mg
RxActive license

Active substance (INN)

trastuzumab emtansine

Pharmaceutical form

Pharmaceutical formPowder for concentrate for solution for infusion
Strength160mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FD03)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateNovember 4, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

KADCYLARx
Powder for concentrate for solution for infusion, 100mgF. Hoffmann-La Roche AG
Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026